XML 77 R54.htm IDEA: XBRL DOCUMENT
v3.25.3

INVESTMENTS IN VARIABLE INTEREST ENTITIES - Narrative (Details) - USD ($) $ in Millions | 1 Months Ended | 3 Months Ended | 9 Months Ended |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Aug. 31, 2025 | Jun. 30, 2025 | May 31, 2025 | Apr. 30, 2025 | Jul. 31, 2024 | Aug. 31, 2022 | Sep. 30, 2025 | Sep. 30, 2024 | Sep. 30, 2025 | Sep. 30, 2024 | Oct. 31, 2025 | Dec. 31, 2024 | Feb. 28, 2023 | Jun. 30, 2022 | Apr. 30, 2021 | Feb. 28, 2019
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Adjustment to additional paid in capital for purchase of noncontrolling interest |  |  |  |  |  |  | $ 233.7 |  |  |  |  |  |  |  |  |
Payment for acquisition options |  |  |  |  |  |  |  |  | $ 19.6 | $ 16.2 |  |  |  |  |  |
Loss on impairment |  |  |  |  |  |  | 0.0 | $ 0.0 | 47.1 | $ 0.0 |  |  |  |  |  |
Investment in preferred equity securities |  |  |  |  |  |  | 167.8 |  | $ 167.8 |  |  | $ 119.1 |  |  |  |
Variable Interest Entity, Primary Beneficiary | Vectorious Medical Technologies |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of noncontrolling interests |  |  |  |  |  |  | $ 233.7 |  |  |  |  |  |  |  |  |
Ownership percentage |  | 61.00% |  |  |  |  | 100.00% |  | 100.00% |  |  |  |  |  |  |
Noncontrolling interest, equity, carrying amount |  |  |  |  |  |  |  |  |  |  |  |  | $ 60.4 |  |  |
Adjustment to additional paid in capital for purchase of noncontrolling interest |  |  |  |  |  |  | $ 173.3 |  |  |  |  |  |  |  |  |
Variable Interest Entity, Not Primary Beneficiary | JenaValve Technology, Inc |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum secured promissory note |  |  |  |  | $ 75.0 |  |  |  |  |  |  |  |  |  |  |
Automatic funding extension clause amount |  |  |  |  | 30.0 |  |  |  |  |  |  |  |  |  |  |
Investee drew additional amount |  |  |  |  |  |  | 75.0 |  | $ 75.0 |  |  | 15.0 |  |  |  |
Termination loan clause |  |  |  |  | $ 45.0 |  |  |  |  |  |  |  |  |  |  |
Variable Interest Entity, Not Primary Beneficiary | JenaValve Technology, Inc | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investee drew additional amount |  |  |  |  |  |  |  |  |  |  | $ 7.5 |  |  |  |  |
Variable Interest Entity, Not Primary Beneficiary | Medical Device Company August 2022 Investment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payment for acquisition options |  |  |  |  |  | $ 47.1 |  |  |  |  |  |  |  |  |  |
Loss on impairment |  | $ 47.1 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payments to option to acquire |  |  |  |  |  |  | 10.0 |  |  |  |  |  |  |  |  |
Variable Interest Entity, Not Primary Beneficiary | Medical Device Company, April 2021 Investment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum secured promissory note |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 45.0 |
Investee drew additional amount |  |  |  |  |  |  | 45.0 |  | 45.0 |  |  | 45.0 |  |  |  |
Payments to option to acquire | $ 1.2 |  |  | $ 1.8 |  |  |  |  |  |  |  |  |  |  |  |
Payments for option to acquire investment | $ 2.6 |  |  | $ 4.0 |  |  |  |  |  |  |  |  |  |  |  |
Investment in preferred equity securities |  |  |  |  |  |  | 45.8 |  | 45.8 |  |  | 42.8 |  |  |  |
Investment option to acquire |  |  |  |  |  |  | 27.5 |  | 27.5 |  |  | 20.9 |  |  |  |
Variable Interest Entity, Not Primary Beneficiary | Medical Device Company, April 2021 Investment | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investee drew additional amount |  |  |  |  |  |  |  |  |  |  | $ 15.0 |  |  |  |  |
Variable Interest Entity, Not Primary Beneficiary | Medical Device Company December 2021 Investment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum secured promissory note |  |  |  |  |  |  |  |  |  |  |  | 40.0 |  |  |  |
Payments to option to acquire |  |  | $ 15.0 |  |  |  |  |  |  |  |  |  |  |  |  |
Payments for option to acquire investment |  |  | $ 10.0 |  |  |  |  |  |  |  |  |  |  |  |  |
Investment in preferred equity securities |  |  |  |  |  |  | 35.0 |  | 35.0 |  |  | 20.0 |  |  |  |
Investment option to acquire |  |  |  |  |  |  | 40.0 |  | 40.0 |  |  | 30.0 |  |  |  |
Variable Interest Entity, Not Primary Beneficiary | Medical Device Company February 2019 Investment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum secured promissory note |  | 30.0 |  |  |  |  |  |  |  |  |  |  |  | $ 47.5 |  |
Investee drew additional amount |  |  |  |  |  |  | 77.5 |  | 77.5 |  |  | 47.5 |  |  |  |
Investment option to acquire |  |  |  |  |  |  | 35.0 |  | $ 35.0 |  |  | $ 35.0 |  |  |  | $ 35.0
Option to extend warrant right period, consideration |  |  |  |  |  |  | $ 16.5 |  |  |  |  |  |  |  |  |
Variable Interest Entity, Not Primary Beneficiary | Medical Device Company June 2025 Investment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investment in preferred equity securities |  | $ 30.0 |  |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Equity Securities, FV-NI, Maximum Secured Promissory Note + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Securities, FV-NI, Maximum Secured Promissory Note, Funding Extension Clause, Amount + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNoteFundingExtensionClauseAmount
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Securities, FV-NI, Option To Acquire Investment + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIOptionToAcquireInvestment
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Securities, FV-NI, Option To Extend Warrant Right Period, Consideration + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIOptionToExtendWarrantRightPeriodConsideration
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Securities, FV-NI Promissory Note Outstanding + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNIPromissoryNoteOutstanding
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Securities, FV-NI, Secured Promissory Note, Termination Loan Clause + References No definition available. + Details
Name: | ew_EquitySecuritiesFVNISecuredPromissoryNoteTerminationLoanClause
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Payments For Option To Acquire Investment + References No definition available. + Details
Name: | ew_PaymentsForOptionToAcquireInvestment
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Variable Interest Entity, Loss On Impairment + References No definition available. + Details
Name: | ew_VariableInterestEntityLossOnImpairment
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1 + Details
Name: | us-gaap_EquitySecuritiesFvNi
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 23 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-23 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-24 + Details
Name: | us-gaap_MinorityInterestDecreaseFromRedemptions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_OtherPaymentsToAcquireBusinesses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the purchase of noncontrolling interest during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 19 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-19 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 1 -SubTopic 10 -Topic 321 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479567/321-10-45-1 + Details
Name: | us-gaap_PaymentsToAcquireEquitySecuritiesFvNi
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 480 -SubTopic 10 -Name Accounting Standards Codification -Section S45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 480 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 480 -SubTopic 10 -Name Accounting Standards Codification -Section S45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 480 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3A -Subparagraph (24) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 480 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (01)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1 + Details
Name: | us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 860 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (b)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 860 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (b)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 860 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A + Details
Name: | us-gaap_VariableInterestEntityLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=ew_VectoriousMedicalTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_JenaValveTechnologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyAugust2022InvestmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyApril2021InvestmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyDecember2021InvestmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyFebruary2019InvestmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyJune2025InvestmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |